Novel genes of visceral adiposity: Identification of mouse and human Mesenteric Estrogen-Dependent Adipose (MEDA)-4 gene and its adipogenic function

Endocrinology

Volumn 153, Issue 6, 2012, Pages 2665-2676

  Zhang, H ^a   Chen, X ^a   Sairam, M R ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; CD36 ANTIGEN; ESTRADIOL; FATTY ACID SYNTHASE; FOLLITROPIN RECEPTOR; GLUCOSE; HORMONE SENSITIVE LIPASE; LIPID; LIPOPROTEIN LIPASE; MESSENGER RNA; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; SEX HORMONE; SHORT HAIRPIN RNA;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOCRINE DISEASE; ESTROGEN THERAPY; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MEDA 4 GENE; METABOLIC SYNDROME X; MOLECULAR CLONING; MOUSE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OMENTUM; OVARIECTOMY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; RISK FACTOR; SEQUENCE HOMOLOGY; SUBCUTANEOUS FAT;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOSITY; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CLONING, MOLECULAR; FEMALE; HEK293 CELLS; HUMANS; INTRA-ABDOMINAL FAT; LIPID METABOLISM; MALE; MICE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE HORMONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTOME;

EID: 84861321698     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2008     Document Type: Article

References (48)

1. Rosen ED, Spiegelman BM 2006 Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444:847-853 (Pubitemid 46024991)
2. RosanoGM, Vitale C, Fini M 2009 Cardiovascular aspects of menopausal hormone replacement therapy. Climacteric 12:41-46
3. Szmuilowicz ED, Stuenkel CA, Seely EW 2009 Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 5:553-558
4. Garaulet M, Pérez-Llamas F, Baraza JC, Garcia-Prieto MD, Fardy PS, Tébar FJ, Zamora S 2002 Body fat distribution in pre-and postmenopausal women: metabolic and anthropometric variables. J Nutr Health Aging 6:123-126 (Pubitemid 34415238)
5. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB 2003 The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163:427-436 (Pubitemid 36241019)
6. Khandekar MJ, Cohen P, Spiegelman BM 2011 Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11:886-895
7. Tontonoz P, Spiegelman BM 2008 Fat and beyond: the diverse biology of PPARγ. Annu Rev Biochem 77:289-312
8. Otto TC, Lane MD, Cox MM 2005 Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol 40:229-242 (Pubitemid 41140883)
9. Clevers H 2006 Wnt/β-catenin signaling in development and disease. Cell 127:469-480
10. Jimenez MA, Akerblad P, Sigvardsson M, Rosen ED 2007 critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol Cell Biol 27:743-757 (Pubitemid 46080139)
11. Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J 1998 Concentration of sex steroids in adipose tissue after menopause. Steroids 63:319-321 (Pubitemid 28265669)
12. Mayes JS, Watson GH 2004 Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5:197-216 (Pubitemid 39423001)
13. Sairam MR, Wang M, Danilovich N, Javeshghani D, Maysinger D 2006 Early obesity and age-related mimicry of metabolic syndrome in female mice with sex hormonal imbalances. Obesity 14:1142-1154 (Pubitemid 46219680)
14. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR 2000 Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141:4295-4308
15. Ribas V, Nguyen MTA, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, Hevener AL 2010 Impaired oxidative metabolism and inflammation are associated with insulin resistance inER α deficient mice. Am J Physiol Endocrinol Metab 298:E304-E319
16. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735-12740
17. Danilovich N, Maysinger D, Sairam MR 2004 Perspectives on reproductive senescence and biological aging: studies in genetically altered follitropin receptor knockout [FORKO] mice. Exp Gerontol 39:1669-1678 (Pubitemid 39576138)
18. Zhang H, Chen X, Aravindakshan J, Sairam MR 2007 Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance. Endocrinology 148:5667-5679 (Pubitemid 350146141)
19. Schäffler A, Schölmerich J, Büchler C 2005 Mechanisms of Disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2:103-111 (Pubitemid 40790157)
20. Björntorp P 1990 "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10: 493-496 (Pubitemid 20220571)
21. Zhang H, Chen X, Sairam MR 2011 Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome. Diabetologia 54:2368-2380
22. Aravindakshan J, Chen XL, Sairam MR 2010 Chronology and complexities of ovarian tumorigenesis in FORKO mice: age-dependent gene alterations and progressive dysregulation of major histocompatibility complex (MHC) class I and II profiles. Mol Cell Endocrinol 329:37-46
23. Sundaram S, Lee LK, Roth CM 2007 Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity. Nucleic Acids Res 35:4396-4408 (Pubitemid 47244591)
24. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808 (Pubitemid 38063703)
25. Gustafson B, Smith U 2010 Activation of canonical wingless-type MMTVintegration site family (Wnt) signaling in mature adipocytes increases b-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem 285:14031-14041
26. Núñez NP, Carpenter CL, Perkins SN, Berrigan D, Jaque SV, Ingles SA, Bernstein L, Forman MR, Barrett JC, Hursting SD 2007 Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity 15:1980-1987 (Pubitemid 47402230)
27. Medina EA, AfsariRR,Ravid T, Castillo SS, Erickson KL, Goldkorn T 2005 Tumor necrosis factor-α decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 146:2726-2735 (Pubitemid 40695576)
28. Cinti S 2001 The adipose organ: morphological perspectives of adipose tissues. Proc Nutr Soc 60:319-328
29. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM 2000 Transcriptional regulation of adipogenesis. Genes Dev 14:1293-1307 (Pubitemid 30397073)
30. Smas CM, Sul HS 1993 Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73:725-734 (Pubitemid 23159011)
31. Zhou YT, Wang ZW, Higa M, Newgard CB, Unger RH 1999 Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 96:2391-2395 (Pubitemid 29117925)
32. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS 2002 Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 22:5585-5592 (Pubitemid 34755767)
33. Anghel SI, Wahli W 2007 Fat poetry: a kingdom for PPAR γ. Cell Res 17:486-511
34. Gao X, Li K, Hui X, Kong X, Sweeney G, Wang Y, Xu A, Teng M, Liu P, Wu D 2011 Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase. Biochem J 435:723-732
35. Hallenborg P, Jørgensen C, Petersen RK, Feddersen S, Araujo P, Markt P, Langer T, Furstenberger G, Krieg P, Koppen A, Kalkhoven E, Madsen L, Kristiansen K 2010 Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor γ activity. Mol Cell Biol 30:4077-4091
36. Harman-Boehm I, Blüher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Klöting N, Stumvoll M, Bashan N, Rudich A 2007 Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92:2240-2247 (Pubitemid 46997129)
37. Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GSH, Lopez M, Seppänen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A 2007 A PPAR γ 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3:e64
38. Lefterova MI, Lazar MA 2009 New developments in adipogenesis. Trends Endocrinol Metab 20:107-114
39. Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156
40. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ 1995 Impaired energy homeostasis in C/EBP α knockout mice. Science 269:1108-1112
41. Phan J, Péterfy M, Reue K 2004 Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J Biol Chem 279:29558-29564 (Pubitemid 38915837)
42. CaoZ, UmekRM, McKnight SL 1991 Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552 (Pubitemid 21906060)
43. Kaaman M, Ryden M, Axelsson T, Nordstrom E, Sicard A, Bouloumie A, Langin D, Arner P, Dahlman I 2006 ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance. Int J Obes 30:447-452
44. Wang Y, Sun Z 2009 Klotho Gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54: 810-817
45. Oliver-Krasinski JM, Kasner MT, Yang J, Crutchlow MF, Rustgi AK, Kaestner KH, Stoffers DA 2009 The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice. J Clin Invest 119:1888-1898
46. Carr MC 2003 The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88:2404-2411 (Pubitemid 36724404)
47. Munoz J, Derstine A, Gower BA 2002 Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obesity 10:424-431 (Pubitemid 135686633)
48. Cann JA, Register TC, Adams MR, St. Clair RW, Espeland MA, Williams JK 2008 Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice. Atherosclerosis 201:43-52